Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Great volume continues

<< Previous

Bullboard Posts

Next >>

Comment by floatinketuckyon Dec 04, 2021 7:22am

276 Views

Post# 34198003

RE:Great volume continues

I agree and folks are starting to see the murky water of the intial ph2 treatments get flushed out by the clear and very favorable data continuing to stream in. This coupled with the FDA wanting to know. The verification of data in this PH2 PIVITOL STUDY is what is making the value in the stcok so apparant. And awareness of the completly amazing results of the ph1 trial is also starting to get discovered i think. Thats a good bit of DD.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments